Samer Salah

Consultant Medical Oncologist

Education and Training

Higher Specialty Degree in Internal Medicine, Jordan University of Science and Technology (JUST), Jordan
M.B./B.S. University of Jordan, Faculty of Medicine, Jordan
1999-2003 Internal Medicine Resident, King Abdullah University Hospital and Princess Basma Hospital (JUST Residency Program), Jordan
2015-2017 Canadian Fellowship of Medical Oncology and Sarcoma, genitourinary oncology and phase 1 trials, University of Toronto University Health Network, Princess Margaret Hospital and Mount Sinai Hospital, Canada

Board Certifications

Jordanian Board of Medical Oncology
Jordanian Board of Internal Medicine

Experience

2015-2017 Medical Oncology Fellow, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
Sarcoma, Genitourinary cancers, and phase 1 clinical trial- Drug development programs. Princess Margaret Cancer Centre and Mount Sinai Hospital, Canada
2011-2015 Medical Oncologist King Hussein Cancer Center (KHCC), Jordan
2008-2011 Fellow of Medical Oncology, KHCC, Jordan
2005-2008 Intensive Care Unit Physician, KHCC, Jordan
2003-2005 Internal Medicine Specialist & Intensive Care Unit Physician, Shmeisani Hospital, Jordan
Achievements:

12 Conference presentations, including four international presentations at the Annual ASCO (American Society of clinical oncology)/ and ASCO GU meetings
Experience in sarcoma, genitourinary cancers, and phase 1 clinical trials
Sub-investigator/co-investigator for many phase 2 and 3 clinical trials in genitourinary cancers and sarcomas, as well as sub-investigator for numerous phase 1 trials
Co-investigator in the EORTC genitourinary group trials
Many publications and national and international awards
Member of the executive board of Jordan Oncology Society

Professional Memberships

Member of Jordan Medical Association.
Member of the administrative board of Jordan Oncology Society- Chief of Social Committee.
Member of American Society of Clinical Oncology (ASCO).
Member of European Organization of Research and Treatment of Cancer (EORTC).
Former member of the Royal college of Physicians and Surgeons of Ontario (CPSO).

Awards And Honors

The GUMOC Astellas Research award for genitourinary research, Canada. June 2017.For the research proposal: Genomic characterization of Non-bilharzia squamous cell carcinoma of urinary bladder: a pilot study of potential prognostic and predictive biomarkers.
Award of “Best cancer publications, “first winner” by Jordan oncology society 3rd September 2013

Publications

Salah S, Lewin J, Amir E, Abdul Razak A. Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis. Cancer Treat Rev. 2018 May 19;69:1-10
Salah S, Lewin J, Davidson S, Anderson N, Periera SL, et al. Immunoprofiling in alveolar soft part sarcoma. JCO.2017.35.15_suppl.11059
Lewin J, Davidson S, Anderson ND, …, Salah S, Butler MO, Aung KL, Shlien A, Dickson BC, Abdul Razak AR. Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft Part Sarcoma. Cancer Immunol Res. 2018 Jul 17. pii: canimm.0037.2018
Janku F, Abdul Razak A, Gordon M, Brooks D,…,Salah S, et al. Pharmacokinetic-driven phase I study of DCC-2618 a pan-KIT and PDGFR inhibitor in patients (pts) with gastrointestinal stromal tumor (GIST) and other solid tumors. DOI: 10.1200/JCO.2017.35.15_suppl.2515 Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 2515-2515
Mansour A, Abdel-Razeq N, Abuali H, Makoseh M, Shaikh-Salem N, Abushalha K, Salah S. Cement pulmonary embolism as a complication of percutaneous vertebroplasty in cancer patients. Cancer Imaging. 2018 Feb 8;18(1):5. doi: 10.1186/s40644-018-0138-8
Salah S, Lee JL, Rozzi A, Kitamura H, et al. Second-line chemotherapy in older patients with metastatic urothelial carcinoma: Pooled analysis of 10 second-line studies. Clin Genitourin Cancer. 2016 Dec 22. pii: S1558-7673(16)30360-3
Gounder MM, Zer A, Tap WD, Salah S, Dickson MA, et al. Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma. J Clin Oncol. 2016 Sep 10;34(26):3166-74
Salah S, Lee JL, Rozzi A, Kitamura H, Matsumoto K, Srinivas S, Morales-Barrera R, Karles J, Al-Wardat R, Al-rabi K, Maakoseh M. Second-line chemotherapy for metastatic urothelial carcinoma: importance of LN only metastasis as a prognostic factor and construction of a prognostic model. Clin Genitourin Cancer. 2016 Jun;14(3):255-60
Alnimer Y, Salah S, Abuqayas B, Alrabi K. Azacitidine-induced cryptogenic organizing pneumonia: a case report and review of the literature. J Med Case Rep. 2016 Jan 20;10:15
Salah S, Ardissone F, Gonzalez M, Gervaz P, et al. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: Pooled analysis. Ann Surg Oncol. 2015;22(6):1844-50
Salah S, Toubasi S. Factors predicting survival following achievement of complete surgical remission of pulmonary metastasis in osteosarcoma. Mol Clin Oncol. 2015 Jan;3(1):157-162
Salah S, Ahmad R, Sultan I, Yaser S, Shehadeh A. Osteosarcoma with metastasis at initial diagnosis: current outcomes and prognostic factors in the context of a comprehensive cancer center. Mol Clin Oncol. 2014 Sep;2(5):811-816
Yaser S, Salah S, AL-Shatti M, et al. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients. Med Oncol. April 2014, 31:958
Salah S, Salem A. Primary synovial sarcomas of the mediastinum: a systematic review and pooled analysis of the published literature. ISRN Oncol. 2014 Jan 20;2014:412527
Albadainah F, Khader J, Salah S, Salem A. Choroidal metastasis secondary to prostatic adenocarcinoma: case report and review of literature. Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):34-7
Salah S, Al-Ibraheem A, Daboor A, Al-Hussaini M. Synovial sarcoma presenting with huge mediastinal mass: a case report and review of literature. BMC Res Notes. 2013 Jun 25;6:240
Salah S, Yaser S, Salem A, Al Mousa A, Abu Sheikha A, Sultan I. Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen. Med Oncol. 2013 Sep;30(3):639
Nazer L, Alnajjar T, Salah S, Khzouz J, et al. Fatal case of cryptogenic organizing pneumonia associated with everolimus. Ann Saudi Med. 2014 Sep-Oct;34(5):437-9
Salah S, Fayoumi S, Alibraheem A, et al. The influence of pulmonary metastasectomy on survival in osteosarcoma and soft tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy. Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):296-302
Salah S, Watanabe K, Park JS,et al. Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment. Ann Surg Oncol. 2013 Jun;20(6):1955-61
Salah S, Watanabe K, Welter S, et al. Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol. 2012 Oct;23(10):2649-55
Watanabe K, Salah S, Saito N. Comment on: Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 01/2013. (Letter to the editor)
Salah S, Khader J, Yousef Y, Salem A, Al-Hussaini M, Al-Asady R. Choroidal metastasis as the sole initial presentation of metastatic lung cancer. Hematol Oncol Stem Cell Ther. 2012;5(1):60
alah S, Tanvetyanon T, Abbasi S. Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: Systematic review and analysis of reported cases. Lung Cancer. 2012 Jan;75(1):9-14
Hawari FI, Al Najjar TI, Zaru L, Al Fayoumee W, Salah SH, Mukhaimar MZ. The effect of implementing high-intensity intensive care unit staffing model on outcome of critically ill oncology patients. Crit Care Med. 2009 Jun;37(6):1967-71
Salah S, Lott A, Ferguson P, Wunder J, et al. The impact of multimodality therapy in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program Experience. J Clin Oncol 34, 2016 (suppl; abstr 11051)
Salah S, Lee JL, Rozzi A, Lewin JH, et al. Second-line chemotherapy in older patients with metastatic urothelial carcinoma: Pooled analysis of 10 second-line studies. J Clin Oncol 34, 2016 (suppl; abstr e16038)
Ma’koseh M, Salam M, Al-Wardat R, Salah S. Metastatic urothelial tumors progressing following first line chemotherapy: prognostic factors and importance of second line chemotherapy. J Clin Oncol 34, 2016 (suppl; abstr e16036)
Ma'koseh M, Kitamura H, Srinivas S, Lewin JH, Salah S. Platinum retreatment in second line chemotherapy for metastatic urothelial carcinoma (UC): Assessing the concept of platinum sensitivity and predictors of survival. J Clin Oncol 34, 2016 (suppl; abstr e16024)
Salah S, Lee JL, Rozzi A, Kitamura H, et al. Second-line chemotherapy for metastatic urothelial cell carcinoma: Pooled analysis and construction of a prognostic model. J Clin Oncol 33, 2015 (suppl 7; abstr 309
Salah S, Ardissone F, Gonzalez M, Gervaz P, et al. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: Pooled analysis. J Clin Oncol 32:5s, 2014 (suppl; abstr 3553)

Contact Information

Email Address: ds.06907@khcc.jo
Phone Number: 0096265300460 -1166